Empress: four research threads, no combination evidence

A woman lacing her shoes on warm stone steps before a morning walk

Empress is a named combination of MOTS-C, BPC-157, GHK-Cu, and kisspeptin-10. It spans mitochondrial, tissue repair, copper peptide, and reproductive hormone signalling research. No study of the combination was identified, and the inclusion of a reproductive signalling peptide adds specific considerations.

Composition

  • mots-c
  • bpc-157
  • ghk-cu
  • kisspeptin-10

Overview

Of the longevity-theme groupings, this one spans the widest range of biology. Kisspeptin-10 in particular sits in reproductive endocrinology research rather than in the aging or repair literature, and its presence means the evaluation has to include reproductive and hormonal history. That is stated here rather than left implicit.

Why these are grouped

The rationale offered is broad coverage of metabolic, tissue, skin, and hormonal signalling. Four unrelated literatures in one preparation is a merchandising decision. No published work tested the grouping.

What each ingredient contributes

mots-c

A mitochondrial-derived peptide from animal metabolic research, with minimal human data.

bpc-157

Studied in animal models of tissue and gut signalling, with no adequate human trial base.

ghk-cu

A copper-binding peptide with published skin and wound research, largely topical.

kisspeptin-10

A peptide studied in human reproductive endocrinology research on gonadotropin release. Its research context is hormonal, not longevity.

Combination evidence

  • No published or registered study of the Empress combination was identified.
  • No data describe interactions between a reproductive signalling peptide and the other components.
  • No evidence supports outcome claims of any kind for this grouping.

Kisspeptin-10 has legitimate human research in reproductive endocrinology, conducted in controlled settings for physiologic study rather than as a therapy. GHK-Cu has topical skin research. MOTS-C and BPC-157 are preclinical. None of this describes the combination.

Preclinical rationale

  • Mitochondrial-derived peptides appear in animal metabolic models.
  • Copper peptides appear in skin remodelling research.
  • Kisspeptin signalling is an established part of reproductive endocrine physiology and is studied for that reason.

What is not established

  • Any effect of the combination on hormones, metabolism, skin, or aging.
  • Whether reproductive signalling effects are desirable or safe outside a controlled research setting.
  • Safety of the combination at any duration.
  • Effects in people with hormone-sensitive conditions.

Questions to discuss with a physician

  • What does the reproductive signalling component do to my hormones?
  • Given my history, is hormonal signalling something to leave alone?
  • Is there any evidence for the goal I actually have?
  • What would you monitor, and how often?
  • What established options exist instead?

This page is educational. Nothing here can be ordered, and nothing here is a prescription or medical advice. Compounded preparations are not FDA-approved. To ask about current availability, visit goal.md/peptides/connect or call or text 314-907-3103.

Medically reviewed by Michael Fitch, MD, MD. Last reviewed 2026-08-15.